← Eichor
Condition: Central Nervous System Tumour Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Central Nervous System Tumour

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Lo
Phase N/A · 1 location(s) · Cantonal Hospital of St. Gallen · NCT06352710Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours
Phase N/A · 1 location(s) · The University of Western Australia · NCT06951659INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
Phase 1/Phase 2 · 14 location(s) · University Hospital Heidelberg · NCT03838042Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Phase 3 · 4 location(s) · Mayo Clinic · NCT03750227Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
NA · 2 location(s) · Lori Wood · NCT05659524Collecting Information About Treatment Results for Patients With Cushing's Syndrome
Phase N/A · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT03364803Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard
Phase 1 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07179328Intensive Cancer Screening After Cryptogenic Stroke
NA · 1 location(s) · Ottawa Hospital Research Institute · NCT05733416Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Phase 2 · 2 location(s) · Seattle Children's Hospital · NCT06299891Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
NA · 1 location(s) · Northwell Health · NCT05954858Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
Phase 1 · 1 location(s) · Guangzhou JOYO Pharma Co., Ltd · NCT06128148Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis
Phase 4 · 1 location(s) · Fudan University · NCT06230055Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
NA · 1 location(s) · The New York Proton Center · NCT05313191KETOgenic Diet Therapy in Patients With ACROmegaly
NA · 1 location(s) · Erasmus Medical Center · NCT06949891Swiss Spinal Tumor Registry (Swiss-STR)
Phase N/A · 1 location(s) · Luzerner Kantonsspital · NCT06869746A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplan
Phase 2 · 40 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07015242Biological Collection of Brain Tumors
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT05571579Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis
Phase 2 · 1 location(s) · Beijing Tongren Hospital · NCT06510283Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Phase N/A · 3 location(s) · Barts & The London NHS Trust · NCT00461188Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Phase 2 · 3 location(s) · Wake Forest University Health Sciences · NCT02422641International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
Phase N/A · 1 location(s) · Debra Weese-Mayer · NCT03088020Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT07323966Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Canc
Phase 1/Phase 2 · 1 location(s) · Guangzhou Medical University · NCT06462092ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Phase 2 · 22 location(s) · University of Birmingham · NCT05629702Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
NA · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04501705Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179A Twenty-years' Experience in Pituitary Disease.
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06973824GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT06815432R-PMDT Regimen in Newly Diagnosed PCNSL
Phase 2 · 1 location(s) · Zou Dehui · NCT07604987A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05184816
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.